Basel, Switzerland

Andreas Bauer

This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Novartis Ag. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andreas Bauer. Retrieved from https://idiyas.com/inventor/andreas-bauer-ejiw3jg4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

0

Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Liver Disease Treatment by Andreas Bauer

Introduction: Andreas Bauer, located in Basel, Switzerland, is a distinguished inventor and researcher currently associated with Novartis AG. With a focus on advancing treatments for liver diseases, his contributions have significantly influenced the field of medicinal chemistry and therapeutic development.

Latest Patents: Bauer holds a patent titled "Regimes of FXR agonists." This invention details novel regimens involving farnesoid X receptor (FXR) agonists and presents methods for modulating the activity of FXRs. It specifically aims at treating or preventing fibrotic or cirrhotic diseases, particularly those affecting the liver.

Career Highlights: With one patent to his name, Bauer's innovative work has positioned him as a key contributor in the pharmaceutical industry. His research endeavors at Novartis AG showcase a commitment to developing effective therapies for critical health issues.

Collaborations: Bauer collaborates with esteemed colleagues Bryan Laffitte and Michael Badman, enhancing the breadth of expertise in their projects. Together, they work on innovative solutions aimed at tackling liver diseases, leveraging their combined knowledge in biochemistry and pharmacology.

Conclusion: Andreas Bauer's contributions to the field of liver disease treatment through his patent on FXR agonists highlight his role as an influential inventor in the pharmaceutical industry. His ongoing work at Novartis AG, in collaboration with leading professionals, continues to pave the way for breakthroughs in medical treatment and patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…